Limited-Time September Offer: Try 7 Days for Free

AstraZeneca PLC (ZEG.DE) Stock Price

€136.6 0%

Sign up
to add to portfolio

AI Score

  • Alternative

    6
  • Fundamental

    7
  • Technical

    6

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on AstraZeneca PLC, AI stock picks, stock alerts and much more.

Sign up

ZEG.DE AI Stock Analysis

AI stock analysis for ZEG.DE is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like AstraZeneca PLC (ZEG.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

AstraZeneca PLC (ZEG.DE) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of AstraZeneca PLC (ZEG.DE), currently trading at €136.6, will... Sign up to access price prediction.

About ZEG.DE

LSE
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines.

  • Symbol

    ZEG.DE

  • Market

    XETRA

  • Industry

    Drug Manufacturers - General

  • Market Cap

    211.7B

Similar Stocks

PFE.F Pfizer Inc.
PFE.F
€20.42
3.5%
4
AMG.DE Amgen Inc.
AMG.DE
€238.2
0.7%
6
PFE.DE Pfizer Inc.
PFE.DE
€20.9
1.1%
5
IDP.DE Biogen Inc.
IDP.DE
€126.5
1.9%
7
6MK.DE Merck & Co.
6MK.DE
€71.8
1.2%
5

ZEG.DE Alternative Data

Web Traffic

AstraZeneca PLC receives an estimated 1.1M monthly visitors to astrazeneca.com, which is down by -8.9% over the last month.

  • Web Traffic

    1087353

  • Change from Previous Month

    8.9%

  • 3 Month Change

    53.8%

  • YoY Change

    53.8%

Twitter Followers

AstraZeneca PLC has 295,301 Twitter Followers on its main Twitter (also known as X) account, which is down by -0% over the last month.

  • Twitter Followers

    295301

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.1%

  • YoY Change

    0.1%

Facebook Engagement

AstraZeneca PLC has engaged 401 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    401

  • Daily Change

    3.1%

  • 1 Month Change

    289.3%

  • 3 Month Change

    75.1%

  • YoY Change

    75.1%

Instagram Followers

AstraZeneca PLC has 86,676 Instagram Followers on its main Instagram account, up by 1% over the last month.

  • Instagram Followers

    86676

  • Daily Change

    0%

  • 1 Month Change

    1%

  • 3 Month Change

    3.1%

  • YoY Change

    3.1%

Youtube Subscribers

AstraZeneca PLC has 18,900 subscribers on its main Youtube channel, up by 1.1% over the last month.

  • Youtube Subscribers

    18900

  • Daily Change

    0%

  • 1 Month Change

    1.1%

  • 3 Month Change

    3.8%

  • YoY Change

    3.8%

Job Postings

AstraZeneca PLC currenly has an estimated 1,000 open job postings.

  • Job Postings

    1000

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

AstraZeneca PLC has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

3,389,089 are following AstraZeneca PLC on LinkedIn, up by 2% over the last month.

  • LinkedIn Followers

    3389089

  • Daily Change

    2%

  • 1 Month Change

    2%

  • 3 Month Change

    4.7%

  • YoY Change

    4.7%

Business Outlook

According to employee reviews, the business outlook among employees at AstraZeneca PLC is 79 out of 100 (bullish).

  • Business Outlook

    79

  • Change from Previous Month

    0%

  • 3 Month Change

    1.3%

  • YoY Change

    1.3%

LinkedIn Employees

According to LinkedIn, AstraZeneca PLC has 78,688 employees, up by 1.3% over the last month.

  • LinkedIn Employees

    78688

  • Daily Change

    1.3%

  • 1 Month Change

    1.3%

  • 3 Month Change

    3.8%

  • YoY Change

    3.8%

News Mentions

AstraZeneca PLC was mentioned 5 times in the news yesterday.

  • News Mentions

    5

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

ZEG.DE Financials

ZEG.DE Key Metrics
  • Total Revenue

    $13.6B

  • Net Income

    $2.9B

  • Earnings per Share

    $1.88

  • Free cash flow

    $2.7B

  • EBITDA

    $5B

  • EBITDA Ratio

    0.370548

  • Total Assets

    $106.3B

ZEG.DE 2-year Revenue & Income
ZEG.DE 2-year Free Cash Flow

ZEG.DE Technicals

ZEG.DE SMA
ZEG.DE RSI

FAQ

What's the current price of AstraZeneca PLC (ZEG.DE) Stock?
The price of an AstraZeneca PLC (ZEG.DE) share is €136.6.

What's the market cap of AstraZeneca PLC?
The current market cap of AstraZeneca PLC is 211.7B.

What are some stocks similar to AstraZeneca PLC (ZEG.DE) that investors often compare it to?
AstraZeneca PLC (ZEG.DE) is often compared to similar stocks such as Pfizer Inc., Amgen Inc., Pfizer Inc., Biogen Inc. and Merck & Co..

What is the forecast for AstraZeneca PLC's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast AstraZeneca PLC's stock price to be around €142.7 in 2026. Starting from the current price of €136.6, this represents a 4.5% change in price, indicating a neutral outlook for the stock.

How to buy AstraZeneca PLC (ZEG.DE) Stock?
AstraZeneca PLC stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy AstraZeneca PLC shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.